rhodamine 123 has been researched along with AIDS Seroconversion in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Shegokar, R; Singh, KK | 1 |
Aggarwal, S; Andreana, A; Gollapudi, S; Gupta, S; Tsuruo, T; Wien, D | 1 |
2 other study(ies) available for rhodamine 123 and AIDS Seroconversion
Article | Year |
---|---|
Stavudine entrapped lipid nanoparticles for targeting lymphatic HIV reservoirs.
Topics: Animals; Anti-HIV Agents; Calorimetry, Differential Scanning; Cell Survival; Coloring Agents; Drug Compounding; Electrochemistry; Fluorescent Dyes; HIV; HIV Seropositivity; In Vitro Techniques; Lymphatic System; Macrophages; Male; Microscopy, Electron, Transmission; Microscopy, Fluorescence; Nanoparticles; Particle Size; Rats; Rats, Wistar; Rhodamine 123; Stavudine; Tetrazolium Salts; Thiazoles; Tissue Distribution | 2011 |
Abnormal expression of a 170-kilodalton P-glycoprotein encoded by MDR1 gene, a metabolically active efflux pump, in CD4+ and CD8+ T cells from patients with human immunodeficiency virus type 1 infection.
Topics: Adult; ATP Binding Cassette Transporter, Subfamily B, Member 1; CD4-CD8 Ratio; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cyclosporine; Female; Genes, MDR; HIV Seropositivity; Humans; Male; Rhodamine 123; Rhodamines; Zidovudine | 1996 |